Cheetah Therapeutics

Cheetahs chase their prey at an average speed of 60 miles an hour. Cheetah Therapeutics is the first spin-out company that NewCo Ventures has set up. It is focused on oncology, and will preferably address a rare cancer. We have funding for this first spinout. We are now evaluating several oncology molecules and technologies. To discuss potential licensing and partnering arrangements with Dr. Lorna Speid, please email her at LSPEID@SNDTM.COM.

By the way, we chose the name Cheetah Therapeutics to signify our goal to move the licensed molecule through to patients as expeditiously as possible, using our knowledge and expertise in new medicine acceleration.